Virpax Pharmaceuticals logo
Virpax Pharmaceuticals VRPX
$ 0.62 -0.16%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Virpax Pharmaceuticals Financial Statements 2011-2024 | VRPX

Annual Financial Statements Virpax Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

4.54 M 1.02 M 14.2 M - - - - - - - - - -

Shares

1.17 M 1.17 M 6.68 M - - - - - - - - - -

Historical Prices

3.88 0.87 2.13 - - - - - - - - - -

Net Income

-15.2 M -21.7 M -12.1 M -4.34 M -3.31 M -2.64 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-15.7 M -21.8 M -12 M -4.2 M - - - - - - - - -

Interest Expense

- - 92.8 K 148 K - - - - - - - - -

EBITDA

-15.7 M -21.8 M -12 M - -3.18 M -2.63 M - - - - - - -

Operating Expenses

15.7 M 21.8 M 12 M 4.2 M - - - - - - - - -

General and Administrative Expenses

10.6 M 11.1 M 915 K 2.9 M 2.56 M 1.48 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Virpax Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

4.66 M 1.98 M 1.17 M 1.17 M 1.17 M 1.17 M 1.17 M 11.7 M 11.7 M 11.7 M 11.7 M 11.7 M 6.01 M 4.96 M 3.95 M 3.15 M 3.14 M 3.09 M 3.04 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-2.01 M -3.45 M -3.22 M - -5.99 M -3.11 M -1.52 M - -7.64 M -5.88 M -5.14 M - -3.22 M -2.34 M -2.38 M - -1.71 M -1.27 M -656 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-1.92 M -3.46 M -3.3 M - -6.12 M -3.24 M -1.65 M - -7.72 M -5.9 M -5.12 M - -3.25 M -2.31 M -2.35 M - -1.66 M -1.23 M -616 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-82.1 K - - - 121 K - - - - - - - 28.9 K 34 K 30.7 K - 45.7 K 43.3 K 40.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-1.92 M -3.46 M -3.3 M - -6.12 M -3.24 M -1.65 M - -7.72 M -5.9 M -5.12 M - -3.25 M -2.31 M -2.35 M - -1.66 M -1.23 M -616 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

1.92 M 3.46 M 3.3 M - 6.12 M 3.24 M 1.65 M - 7.72 M 5.9 M 5.12 M - 3.25 M 2.31 M 2.35 M - 1.66 M 1.23 M 616 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

781 K 1.5 M 1.69 M - 4.62 M 1.95 M 415 K - 4.91 M 208 K 175 K - 122 K 303 K 370 K - 435 K 572 K 449 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency